KRYSTAL BIOTECH INC (KRYS)
US5011471027 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 358.33M | 161.90M | 341.20M | 268.30M | 187.50M | |||
| Marketable Securities | 173.85M | 217.30M | 96.90M | 3.00M | 6.20M | |||
| Receivables | 42.04M | N/A | N/A | N/A | N/A | |||
| Inventories | 6.99M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 6.71M | 4.60M | 4.20M | 3.80M | 2.20M | |||
| Total Current Assets | 587.91M | 383.80M | 442.30M | 275.10M | 195.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 168.23M | 169.70M | 119.60M | 34.20M | 11.20M | |||
| Investments And Advances | 61.95M | 4.60M | 64.40M | 0.00 | 500.00K | |||
| Other Non-Current Assets | 263.00K | 300.00K | 100.00K | 1.60M | 1.50M | |||
| Total Non-Current Assets | 230.45M | 174.70M | 184.00M | 35.70M | 13.10M | |||
| TOTAL ASSETS | 818.36M | 558.50M | 626.30M | 310.80M | 209.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 24.47M | 24.60M | 17.20M | 5.70M | 2.50M | |||
| Accounts Payable | 4.13M | 4.00M | 8.40M | 2.10M | 700.00K | |||
| Other Current Liabilities | 4.49M | 300.00K | 200.00K | 7.70M | 100.00K | |||
| Total Current Liabilities | 33.09M | 28.80M | 25.70M | 15.50M | 3.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.62M | 7.40M | 7.00M | 3.30M | 2.80M | |||
| Total Non-Current Liabilities | 6.62M | 7.40M | 7.00M | 3.30M | 2.80M | |||
| TOTAL LIABILITIES | 39.71M | 36.20M | 32.70M | 18.80M | 6.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -269.83M | -280.80M | -140.80M | -71.20M | -39.00M | |||
| Additional Paid In Capital | 1.05B | 803.70M | 734.50M | 363.30M | 242.00M | |||
| Common Shares | 280.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 637.72K | -700.00K | -200.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 28.24M | 25.80M | 25.20M | 19.70M | 17.40M | |||
| Tangible Book Value per Share | 27.58 | 20.24 | 23.56 | 14.83 | 11.66 | |||
| Total Shareholders' Equity | 778.64M | 522.20M | 593.60M | 292.10M | 202.90M | |||
| TOTAL LIABILITIES AND EQUITY | 818.36M | 558.50M | 626.30M | 310.80M | 209.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 17.76 | 13.33 | 17.21 | 17.75 | 59.36 | |||
| Return On Assets (ROA) | 1.34% | -25.06% | -11.11% | -10.35% | -9.13% | |||
| Return On Equity (ROE) | 1.40% | -26.81% | -11.72% | -11.01% | -9.41% | |||
All data in USD